Company News
Glenmark Launches Vancomycin Hydrochloride Injection in US
Glenmark Pharmaceuticals Inc., USA launched Vancomycin Hydrochloride for Injection USP in 500 mg/vial and 1 g/vial strengths.
The product is bioequivalent to Fresenius Kabi's reference drug and addres
